News Category
RC Medical's physician-first venture studio model, highlighted by CEO David Ferrera, prioritizes clinical problems over engineering ideas to create de...
D. Boral Capital's initiation of coverage on QT Imaging with a Buy rating and $9 price target highlights the potential of its radiation-free Breast Ac...
Coherence Neuro's $45 million Series A, led by Peter Thiel's Founders Fund and the OpenAI Startup Fund, will fund the first chronic human trial of its...
Adaptogenics Health Corp. is pursuing a three-pronged strategy in the peptide sector, combining supply infrastructure, proprietary therapeutics and in...
The Dr. Kerry Evans Scholarship for Sciences is now accepting applications for its 2027 award, offering $1,000 to undergraduate science students and e...
Dr. Hamid Alam's new scholarship for future doctors offers $1,000 to an undergraduate pre-med student, highlighting the importance of early support an...
Neovii Pharmaceuticals is launching a pivotal Phase 2 study of ATLG in Type 1 Diabetes, supported by FDA Fast Track designation, and has named Salvato...
Nano-X Imaging is developing a platform to expand access to advanced medical imaging in underserved regions by combining digital 3D tomosynthesis with...
A Yale study reveals that recurrent brain cancers develop mutations that differ by subtype, suggesting a shift from phenotype-based to DNA-guided trea...
NextPlat's PharmcoRx subsidiary plans to install VendRx automated prescription dispensing kiosks at clinics starting in Q4 2026, a move that could imp...
ECGI Holdings' placement in an AINewsWire editorial highlights the growing role of AI in preventive care and the company's strategic acquisition of Av...
Regentis Biomaterials is developing GelrinC, a degradable hydrogel implant designed to regenerate durable knee cartilage, reflecting a broader shift i...
ECGI Holdings has hired IBN to expand investor awareness of its health care strategy, which includes building an integrated care ecosystem and develop...
Datavault AI's letter of intent to acquire a 19.9% stake in DataMEDS AI in exchange for expanding a technology license could create a new royalty stre...
Annovis Bio's three presentations at the 2026 CTAD conference will showcase buntanetap's mechanism, Phase 3 trial design, and AI-driven blood-brain ba...
Nano-X Imaging is developing a platform to extend advanced medical imaging to underserved settings, addressing global disparities in diagnostic access...
NeuroThera Labs has completed manufacturing and obtained European QP batch release certification for its SCI-110 investigational drug, enabling shipme...
tZERO Securities will provide regulated broker-dealer and ATS infrastructure to Temple Digital Group, enabling Temple to offer tokenized securities tr...
AgeReverse's flagship RESURGE supplement is now available on OneLavi.com, extending the Canadian longevity brand's U.S. distribution beyond Amazon and...
Circus SE's Q3 2026 update shows it now operates Europe's largest fleet of autonomous meal production robots, with over 30 systems deployed across 19 ...
VERAXA Biotech is implementing New Approach Methodologies across its preclinical research programs, aiming to improve the clinical relevance of its an...
VERAXA Biotech is advancing its BiTAC platform to improve the selectivity of antibody-based cancer therapies, potentially reducing toxicity while main...
ECGI Holdings' acquisition of Avanta Group positions it to capitalize on the growing role of AI in preventive healthcare, as highlighted in a recent A...
HeartBeam's early completion of enrollment in its HEADSTART-ACS study accelerates the development of its portable 3D ECG technology for heart attack d...
A 34-country analysis of ADHD-related disability across Asia identifies early adolescence as the period of greatest impact, with sharp regional contra...
Battle Born Clothing has expanded its custom Carhartt workwear program, adding equipment and capacity to better serve construction, mining, trades and...
A new scorecard from the Special Competitive Studies Project finds the United States still leads China in biotechnology but risks losing that edge by ...
BioVersys announced peer-reviewed publications showing BV100 achieves high lung concentrations and has a manageable drug interaction profile, strength...
SS Innovations International (NASDAQ: SSII) has launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo, marking a signif...
Regentis Biomaterials has achieved a 400% increase in production yield for its GelrinC cartilage repair implant following European regulatory approval...
Quantum BioPharma's Unbuzzd alcohol recovery formulation gained mainstream attention through a Men's Fitness article, but the coverage highlights both...
Scinai Immunotherapeutics announced a more than 300% increase in committed CDMO orders to $8.1 million and $5.3 million in net financing proceeds, ext...
Bangladesh's major measles outbreak, with over 200,000 suspected cases, highlights the global risk of falling vaccination rates and serves as a cautio...
The Department of Health and Human Services has granted $1.5 million to two healthcare research organizations to advance agentic AI and laboratory int...
NanoViricides reports positive juvenile animal safety results for its broad-spectrum antiviral NV-387, potentially enabling pediatric trials for Ebola...
ECGI Holdings' acquisition of Avanta Group positions it to capitalize on the shift toward preventive, coordinated care, as highlighted in an AINewsWir...
Oncotelic Therapeutics' CBO Saran Saund will deliver a keynote on the company's PDAOAI platform and AI-enabled drug discovery strategy at the 22nd Dru...
VERAXA Biotech is expanding its use of FDA-aligned New Approach Methodologies to generate more clinically relevant preclinical data while reducing ani...
tZERO's CFTC approval as a derivatives clearing organization opens a new derivatives vertical, enabling institutional clients to offer multi-asset pro...
Dr. Mona Mofid's ninth San Diego Top Doctor award, paired with a 2026 Top Specialist Award and perfect patient ratings, underscores a two-decade recor...
Pentixapharm's Phase 3 PANDA study for non-invasive subtyping of primary aldosteronism is reinforced by independent international data presented at EA...
Nanox subsidiary Nanox AI has signed a distribution agreement with Technologic s.r.l. to commercialize its AI-powered bone health solution HealthOST i...
Stocktwits' Stocktoberfest 2026 in New York City drew over 350 attendees and 40 financial creators with a combined following of 11 million, signaling ...
Quantum BioPharma's Unbuzzd alcohol recovery formulation gained mainstream attention through a Men's Fitness article that highlighted promising but li...
Gold prices bounced 1% in Asian trading after a sharp sell-off, but the rebound may be short-lived as inflation data points to further Fed tightening,...
The IMF has cautioned that a sharp decline in AI stock prices could rapidly spread through global markets due to the deep interconnectedness of invest...
A small German study's eight-year follow-up shows two-thirds of patients with aggressive brain tumors were still alive and 42% had no recurrence, unde...
Cotecna Group's acquisition of Energon Labs strengthens its global life sciences platform and expands pharmaceutical testing capabilities in India, on...
